Literature DB >> 18501484

Influenza immunization and subsequent diagnoses of group A streptococcus-illnesses among U.S. Army trainees, 2002-2006.

Seung-eun Lee1, Angelia Eick, Michael S Bloom, John F Brundage.   

Abstract

To assess the association between influenza immunization and subsequent diagnosis of group A streptococcus (GAS)-illness in Army recruits during influenza seasons 2002-2006. A case-control study was employed with cases as trainees with outpatient GAS diagnosis (ICD-9-CM codes: 034.0, 035, 038.0, 041.01, 320.2, 390-392, 482.31) during the influenza season, and controls as trainees with no outpatient GAS diagnosis during the influenza season. Primary exposure was influenza immunization during 1st September to 30th April of each season. Estimated protective effects of influenza immunization against GAS-illness ranged from 50% to 77%. A strong protective effect was suggested for Army trainee influenza immunization on the diagnosis of GAS-illness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501484     DOI: 10.1016/j.vaccine.2008.04.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

Review 2.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

3.  Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Authors:  Michael S Chaussee; Heather R Sandbulte; Margaret J Schuneman; Frank P Depaula; Leslie A Addengast; Evelyn H Schlenker; Victor C Huber
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

Review 4.  Respiratory Infections in the U.S. Military: Recent Experience and Control.

Authors:  Jose L Sanchez; Michael J Cooper; Christopher A Myers; James F Cummings; Kelly G Vest; Kevin L Russell; Joyce L Sanchez; Michelle J Hiser; Charlotte A Gaydos
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Authors:  Joshua M Klonoski; Heather R Hurtig; Brian A Juber; Margaret J Schuneman; Thomas E Bickett; Joshua M Svendsen; Brandon Burum; Thomas A Penfound; Grigoriy Sereda; James B Dale; Michael S Chaussee; Victor C Huber
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641

Review 6.  Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Authors:  Samson Sy Wong; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-07-11       Impact factor: 7.163

7.  Invasive bacterial infections following influenza: a time-series analysis in Montréal, Canada, 1996-2008.

Authors:  R Allard; M Couillard; P Pilon; M Kafka; L Bédard
Journal:  Influenza Other Respir Viruses       Date:  2011-10-10       Impact factor: 4.380

Review 8.  Secondary Bacterial Infections Associated with Influenza Pandemics.

Authors:  Denise E Morris; David W Cleary; Stuart C Clarke
Journal:  Front Microbiol       Date:  2017-06-23       Impact factor: 5.640

9.  Influenza vaccination accelerates recovery of ferrets from lymphopenia.

Authors:  Nedzad Music; Adrian J Reber; Aleksandr S Lipatov; Ram P Kamal; Kristy Blanchfield; Jason R Wilson; Ruben O Donis; Jacqueline M Katz; Ian A York
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

Review 10.  The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Authors:  Andrea L Herrera; Victor C Huber; Michael S Chaussee
Journal:  Front Microbiol       Date:  2016-03-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.